Family PracticeNursingPulmonologyInternal MedicineCritical CareEmergency MedicineNephrologyConditionsKidney ProblemsInfectious DiseaseCoronavirus
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, July 10, 2020 (HealthDay News) -- Many outpatient kidney transplant recipients with COVID-19 have symptomatic resolution without requiring hospitalization, and hospitalized COVID-19 patients on hemodialysis have worse outcomes than those without kidney failure, according to two studies recently published in the Clinical Journal of the American Society of Nephrology.
S. Ali Husain, M.D., from the Columbia University College of Physicians and Surgeons in New York City, and colleagues obtained clinical data for 41 consecutive kidney transplant recipients seen as outpatients for known or suspected COVID-19 (22 confirmed cases; 19 suspected cases). The researchers found that patients most often reported fever, cough, and dyspnea (80, 56, and 39 percent, respectively). Thirteen patients (32 percent) required hospitalization at a median of eight days after onset of symptoms; 23 (56 percent) had outpatient symptom resolution at a median of 12 days after onset of symptoms. Patients who required hospitalization were more likely to have reported dyspnea and had higher baseline creatinine.
Jun Wu, from the Wuhan University in China, and colleagues conducted a retrospective study involving 49 patients on maintenance hemodialysis and 52 patients without kidney failure who were all hospitalized for confirmed COVID-19. The researchers found differences in fatigue, dry cough, and fever for patients on hemodialysis versus controls (59 versus 83 percent; 49 versus 71 percent; 47 versus 90 percent, respectively). Patients on hemodialysis received more noninvasive ventilation (25 versus 6 percent); three patients received invasive ventilation (6 percent) and seven died (14 percent).
"As a nephrology community, we know that optimal COVID-19 disease management is still being debated, and the therapeutic approach still lacks significant evidence," write the authors of an accompanying editorial.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 25, 2022
Read this Next
Other Trending Articles